Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Verona Pharma PLC ADR is a biotechnology business based in the US. Verona Pharma PLC ADR shares (VRNA) are listed on the NASDAQ and all prices are listed in US Dollars. Verona Pharma PLC ADR employs 24 staff and has a trailing 12-month revenue of around $40 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $8.63 |
|---|---|
| 52-week range | $3.41 - $14.69 |
| 50-day moving average | $9.05 |
| 200-day moving average | $6.07 |
| Wall St. target price | $24.71 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.99 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $8.63 from 2022-09-23
| 1 week (2022-09-19) | -12.30% |
|---|---|
| 1 month (2022-08-26) | -18.20% |
| 3 months (2022-06-24) | 92.63% |
| 6 months (2022-03-25) | 62.52% |
| 1 year (2021-09-24) | 59.81% |
|---|---|
| 2 years (2020-09-25) | 34.21% |
| 3 years (2019-09-26) | 90.93% |
| 5 years (2017-09-26) | 15.04 |
| Revenue TTM | $40 million |
|---|---|
| Gross profit TTM | $40 million |
| Return on assets TTM | -17.09% |
| Return on equity TTM | -41.33% |
| Profit margin | -137.04% |
| Book value | $1.83 |
| Market capitalisation | $526 million |
TTM: trailing 12 months
We're not expecting Verona Pharma PLC ADR to pay a dividend over the next 12 months.
Over the last 12 months, Verona Pharma PLC ADR's shares have ranged in value from as little as $3.408 up to $14.69. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Verona Pharma PLC ADR's is 0.4598. This would suggest that Verona Pharma PLC ADR's shares are less volatile than average (for this exchange).
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom. .
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.